News

FDA grants Zenith's ZEN-3694 Fast Track Status
Zenith Epigenetics Announces Grant of U.S. Food and Drug Administration Fast Track Designation for ZEN-3694 in NUT Carcinoma Calgary, Alberta--(Newsfile Corp. - July 14, 2025) - Zenith Epigenetics Ltd ...
OS Therapies Inc. (NYSE-A: OSTX) Makes Important Strides In Rare Cancer Therapy
The global oncology drug market is currently valued at over 200 billion dollars and is expected to more than double to 532 billion dollars by 2031. T ...
Adaptive Clinical Protocol Design for Phase II MPox Clade I Treatment with a Novel Broad-Spectrum Drug NV-387 is Almost Complete, Reports NanoViricides
SHELTON, CT / ACCESS Newswire / July 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of bro ...